Heimer at al. show that a novel intravenous #Tantalum oxide nanoparticle #ContrastAgent provides contrast advantages compared to #Iopamidol for improved visualization of thoracic arteries and veins in a multiphase #CT protocol. #LMUradiology #UCSFimaging

t.co/cNCylQophB